GN

Gandhinagar Narasimaiah Basavaraja

Active Director Director DIN 10972592
DIN 10972592 First appointment Feb 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Gandhinagar Narasimaiah Basavaraja

Data last updated:

Gandhinagar Narasimaiah Basavaraja is a Director at Sri Hasanamba Multispeciality Hospital Private Limited (since 2025). The company operates in Healthcare.

DIN 10972592
Primary Designation Director
Industry Healthcare
First Appointment 26 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Feb 20252025Active

Board colleagues of Gandhinagar Narasimaiah Basavaraja

Directorship timeline

Open interactive timeline →
Sri Hasanamba Multispeciality Hospital Private Limited
Premium access

Shareholding and investment profile for Gandhinagar Narasimaiah Basavaraja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gandhinagar Narasimaiah Basavaraja

Gandhinagar Narasimaiah Basavaraja currently holds 1 directorship: Sri Hasanamba Multispeciality Hospital Private Limited (Director, since 26 Feb 2025).

Gandhinagar Narasimaiah Basavaraja was first appointed on 26 Feb 2025 as Director at Sri Hasanamba Multispeciality Hospital Private Limited.

The current boards of Gandhinagar Narasimaiah Basavaraja's companies include Shashikala Patil (Sri Hasanamba Multispeciality Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available